BEZUCLASTINIB FORMULATIONS

The disclosure relates to formulations of bezuclastinib, methods of making such formulations, and methods of using such formulations in the treatment of conditions, diseases, or disorders that would benefit from modulation of c-Kit protein kinases and /or mutant c-kit protein kinases. La divulgation...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	CROWLEY, Michael M, SAHIN, Hulya, BARNETT, Bradley, ROSINOVSKY, Elodie
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The disclosure relates to formulations of bezuclastinib, methods of making such formulations, and methods of using such formulations in the treatment of conditions, diseases, or disorders that would benefit from modulation of c-Kit protein kinases and /or mutant c-kit protein kinases. La divulgation concerne des formulations de bezuclastinib, des procédés de fabrication de telles formulations, et des méthodes d'utilisation de telles formulations dans le traitement d'états pathologiques, de maladies ou de troubles qui bénéficieraient d'une modulation de protéines kinases c-kit et/ou de protéines kinases c-kit mutantes.